Top Tweets for #Labpmm
Heading to #ICCS2026 in Miami! Meet Dr. Hong Drum of #LabPMM at booth #405 to explore our globally standardized MFC assays for #AML & #CLL #MRD.
Let's talk Flow! https://t.co/3hzqcQ6Km8
#Invivoscribe #Diagnostics #PrecisionMedicine #Oncology #FlowCytometry #Hematopathology
For 30+ yrs, #Invivoscribe has been Improving Lives w/Precision Diagnostics®. W/#LabPMM, we provide standardized testing for leukemias, myelomas & lymphomas. Thanks to #researchers, #clinicians, lab pros & partners & to patients & families. https://t.co/CxMVqiIMOZ #Oncology #MRD
Stop by poster #H029 presented by Paulina Gomez at the #AMPath2025 poster session on November 15 from 9:15-10:15 AM to learn about our AML testing services.
Visit https://t.co/IsEc1n3LjS to learn more about MyAML and MyMRD.
#LabPMM #AML #GenePanels #MRD
We are pleased to share a recent publication from #LabPMM, covering interpretation, tracking and reporting of #KMT2A fusions in #AML. Read the full publication here: https://t.co/5lWzNk1BIK
#MeninInhibitors #Drugdevelopment #MyMRD #MyAML
#CERoTherapeutics announces a supportive partnership with @Invivoscribe. This allows $CERo to utilize #LabPMM’s (#Invivoscribe’s global reference laboratories) customized multiparametric flow cytometry (MFC) services and implemented sensitive MFC AML MRD assay for translational and product assessments to support the Company’s lead compound, CER-1236.
This #clinicaltrial targets #AcuteMyeloidLeukemia (#AML) in patients who are relapsed/refractory, in remission with MRD, or newly diagnosed with TP53-mutated MDS/AML.
Read Invivoscribe’s press release here: https://t.co/ERMY7UZvAf
We're proud to support CERo Therapeutics in advancing CER-1236, a novel T cell therapy for AML. Our customized MFC AML MRD assay supported their trial—now granted FDA Orphan Drug Designation. https://t.co/dtmznmhWHX
#AML #MRD #ClinicalTrials #FlowCytometry
We are at #ASCO24! Join us again tomorrow from 9 am at booth 34087 to learn about our ultra-sensitive globally standardized flow & molecular services offered at our global network of accredited labs #LabPMM
#MRD #MFC #CDx #OncologyResearch #PrecisionMedicine
Visit us TOMORROW at #ASCO24 to learn about our ultra-sensitive globally standardized flow & molecular services offered at our global network of accredited labs #LabPMM #MRD #MFC #CDx #OncologyResearch #PrecisionMedicine
Visit us at #ASCO24, #EHA2024, and #AMPEurope2024 to learn about our ultra-sensitive globally standardized flow & molecular services offered at our global network of accredited labs #LabPMM #MRD #MFC #CDx #OncologyResearch #PrecisionMedicine
March is #MyelomaACTIONMonth! We invite you to share your #MYelomaSTORY. Invivoscribe is dedicated to improving lives with precision diagnostics. If you’d like to help us make a difference, join our team. Apply today: https://t.co/3oLqPlVUTI
#myeloma #invivoscribe #labpmm
We're here at booth #931 for day two of #AMPath22! Come by to learn about the new FLT3 ITD MRD Assay we offer for your in-house AML MRD research needs! #invivoscribe #LabPMM #AML #FLT3
Join our AMP corporate workshops on Nov. 2nd to learn about our hemato-oncology solutions from our collaborators from Stanford University and Roswell Park Comprehensive Cancer Center. #invivoscribe #LabPMM #AMPath22
We are at #EHA2022 in Vienna! Join us today at 4:30 pm at a poster session to learn from our expert about Invivoscribe’s new B-cell MRD Assay performance.
See you at the poster number P1263.
#invivoscribe #LabPMM #MRD #EHA
How does YOUR Clonality Testing compare? Watch Invivoscribe's FREE webinar on Thursday, May 19th with Dr. Rena Xian from Johns Hopkins School of Medicine to find out! REGISTER FOR FREE TODAY: https://t.co/x7qw1yElsh #invivoscribe #labpmm #NGS
For over 25 years Invivoscribe has been supporting and providing diagnostics to clinicians, researchers, and laboratories to improve the lives of patients around the world.
Learn more: https://t.co/QitSZzm8Ov
#MYelomaACTION #invivoscribe #LabPMM #myeloma
March is Myeloma Action Month. For over 25 years Invivoscribe has been providing diagnostics to clinicians, researchers, and laboratories to improve the lives of patients around the world. Learn more: https://t.co/QitSZzm8Ov #MYelomaACTION #invivoscribe #LabPMM #myeloma
Make sure to watch our very own Chief Medical Officer, Dr. Bradley Patay speak about, "Artificial Intelligence (AI) and other Data Science Applications in Molecular Pathology!" This #AMPath20 workshop will be available On-Demand on Nov. 16th! #invivoscribe #labpmm
We are very excited to launch a new division of our company, Invivoscribe Therapeutics! View our latest press release: https://t.co/1kjaZKy7nF #Invivoscribe #Labpmm #drugdevelopment #precisiondiagnostics #therapeutics #personalizedmedicine #companiondiagnostics
【#中医協総会（11月14日）】＜＃臨床検査の保険適用＞＃FLT3遺伝子検査（PCR法及びキャピラリー電気泳動法）（販売名；#リューコストラットCDx ＃FLT3変異検査、#LabPMM 合同会社）が12月１日にE３（新項目）として、D006-2（2,100点）の２項目分（4,200点）を準用する検査として保険適用予定です。
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers